Search Results for

11-16 of 16

HPV OncoTect 3Dx™

Our CE-IVD HPV OncoTect 3Dx™ for in vitro diagnostic, provides quantitative information on two levels, the quantity of E6, E7 overexpression inside each and every cell and DNA proliferation status of cells to determine cells that have both high proliferative activity as well as oncogene overexpression. Unmet Medical Need HR HPV is a necessary cause of … Continued

incellPREP (IVD/CE-IVD)

A non-enzymatic approach for preparing intact, single cell suspensions from tissue Enzyme free, single cell suspension with intact nuclei Ready to use in downstream molecular and protein marker analysis Single use micro-homogenizers produce results in under 10 minutes Battery Pack and Sample Rack sold separately Product Code: K17020, K17008, K15008   Related Links incellPREP Brochure – … Continued

Literature

HPV Grundhoefer, D., Patterson, B.K. Determination of Liquid-Based Cervical Cytology Specimen Adequacy Using Cellular Light Scatter and Flow Cytometry. Cytometry. 2001; 46: 340-344. Polina, R., Sturgis, C., Patterson, J., Patterson, B.K. Rapid High Throughput Determination of Cervical Cytology Specimen Adequacy Using a Capillary-Based Cytometer. Cytometry. 2008; 74B: 133-136. Kottaridi, C., Georgoulakis, J., Kassanos, D., Pappas, A., Spathis, … Continued

HPV

The unique proprietary method of our CE-IVD HPV OncoTect® E6, E7 mRNA assay for in vitro diagnostic, provides quantitative information on two levels, the quantity of E6/E7 overexpression inside each and every cell and the percentage of cells that are overexpressing E6/E7 mRNA. Unmet Medical Need HR HPV is a necessary cause of cervical cancer. HR HPV … Continued

CMV mRNA Probe

The CMV mRNA probe determines actively replicating CMV by detecting and quantifying CMV mRNA in individual cells. Item Number: E21100 *For Research Use Only. Not for use in diagnostic procedures.

hdr-news

News

Updates ACTC 2019 IncellDx exhibiting and presenting on "Combined Single-Cell Analysis of Solid Tumors and CTCs for Comprehensive Patient Management" AACR 2019 Connecting aneuploidy and CTCs - IncellDx IncellDx to Study Maraviroc, a CCR5 antagonist, in a COVID-19 Phase 2 Clinical Trial October 19, 2020 IncellDx Awarded PD-L1 Detection and Quantification Paten in Tumor cells and … Continued